1. Home
  2. RENB vs SBI Comparison

RENB vs SBI Comparison

Compare RENB & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENB
  • SBI
  • Stock Information
  • Founded
  • RENB 2011
  • SBI 1992
  • Country
  • RENB United States
  • SBI United States
  • Employees
  • RENB N/A
  • SBI N/A
  • Industry
  • RENB Biotechnology: Pharmaceutical Preparations
  • SBI Finance/Investors Services
  • Sector
  • RENB Health Care
  • SBI Finance
  • Exchange
  • RENB Nasdaq
  • SBI Nasdaq
  • Market Cap
  • RENB 61.0M
  • SBI 111.3M
  • IPO Year
  • RENB N/A
  • SBI N/A
  • Fundamental
  • Price
  • RENB $0.32
  • SBI $7.56
  • Analyst Decision
  • RENB
  • SBI
  • Analyst Count
  • RENB 0
  • SBI 0
  • Target Price
  • RENB N/A
  • SBI N/A
  • AVG Volume (30 Days)
  • RENB 736.8K
  • SBI 39.5K
  • Earning Date
  • RENB 05-19-2025
  • SBI 01-01-0001
  • Dividend Yield
  • RENB N/A
  • SBI 4.52%
  • EPS Growth
  • RENB N/A
  • SBI N/A
  • EPS
  • RENB N/A
  • SBI N/A
  • Revenue
  • RENB N/A
  • SBI N/A
  • Revenue This Year
  • RENB N/A
  • SBI N/A
  • Revenue Next Year
  • RENB N/A
  • SBI N/A
  • P/E Ratio
  • RENB N/A
  • SBI N/A
  • Revenue Growth
  • RENB N/A
  • SBI N/A
  • 52 Week Low
  • RENB $0.29
  • SBI $6.96
  • 52 Week High
  • RENB $2.34
  • SBI $8.00
  • Technical
  • Relative Strength Index (RSI)
  • RENB 36.60
  • SBI 48.09
  • Support Level
  • RENB $0.29
  • SBI $7.52
  • Resistance Level
  • RENB $0.35
  • SBI $7.75
  • Average True Range (ATR)
  • RENB 0.05
  • SBI 0.07
  • MACD
  • RENB 0.01
  • SBI 0.02
  • Stochastic Oscillator
  • RENB 16.20
  • SBI 48.65

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.

Share on Social Networks: